Back to Search Start Over

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.

Authors :
Kiliti, Amber J.
Sharif, Ghada M.
Martin, Mary Beth
Wellstein, Anton
Riegel, Anna T.
Source :
Frontiers in Endocrinology; 2023, p01-15, 15p
Publication Year :
2023

Abstract

The estrogen receptor alpha (ER ) is a steroid receptor that is pivotal in the initiation and progression of most breast cancers. ER regulates gene transcription through recruitment of essential coregulators, including the steroid receptor coactivator AIB1 (Amplified in Breast Cancer 1). AIB1 itself is an oncogene that is overexpressed in a subset of breast cancers and is known to play a role in tumor progression and resistance to endocrine therapy through multiple mechanisms. Here we review the normal and pathological functions of AIB1 in regard to its ER α-dependent and ER α-independent actions, as well as its genomic conservation and protein evolution.We also outline the efforts to target AIB1 in the treatment of breast cancer. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16642392
Database :
Complementary Index
Journal :
Frontiers in Endocrinology
Publication Type :
Academic Journal
Accession number :
171945414
Full Text :
https://doi.org/10.3389/fendo.2023.1250218